Swiss drugmaker Novartis said on Friday it had won U.S. approval to sell the first once-a-year treatment for the bone-thinning disease osteoporosis.
The drug, Reclast, is administered annually in a 15-minute infusion for women with post-menopausal osteoporosis.
It will compete with osteoporosis pills that are taken daily, weekly or monthly.
More
No comments:
Post a Comment